Value Bridge — PALOMAR MEDICAL CENTER ESCONDIDO
Current $13M → Target $29M (+$16.2M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$12.5M
Current EBITDA
$28.8M
Target EBITDA
+$16.2M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$2.9M
Coding Accuracy Uplift
$3.2M
Payer Mix Optimization
$7.6M
Cost to Collect Reduction
$2.5M
Clean Claim Improvement
$1.9M
Volume & Rate Growth
$12.6M
What This Means
The 7-lever model projects a 129% EBITDA uplift from $13M to $29M. The highest-impact lever is Volume & Rate Growth at $5.0M probability-weighted.
IC talking point: "We see $16M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $178M in equity value creation."